A group of international experts is proposing a first-of-its-kind framework to prevent multiple sclerosis (MS) from ...
The company recently hit significant roadblocks with its BTK inhibitor, but there are plenty of fish in the sea for the drug ...
Autoimmune diseases such as multiple sclerosis arise when the immune system turns against the body itself. Yet for most of ...
Recent findings suggest that the Epstein-Barr virus (EBV) is involved in both causing multiple sclerosis (MS) and shaping its ...
There may be two distinct subtypes of multiple sclerosis, according to a new study led by scientists at University College ...
Other prenatal exposures -- preterm birth (before 37 weeks gestation), placental abruption, and maternal hypertensive ...
The immune system's reaction to the common Epstein-Barr virus can ultimately damage the brain and contribute to multiple ...
One of the leading triggers for multiple sclerosis (MS) is an infection with the Epstein-Barr virus. However, certain gene variants also play an important role.
Ongoing clinical trials are exploring therapies like tolebrutinib, fingolimod, and ocrelizumab, focusing on efficacy and safety in diverse patient populations. The MUSETTE trial confirmed that the ...
Researchers at McMaster University in Hamilton are observing people with multiple sclerosis as they exercise while they play ...
ETHealthworld.com brings latest multiple sclerosis news, views and updates from all top sources for the Indian Health industry.